๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunomonitoring and prognostic relevance of neutrophils in clinical trials

โœ Scribed by Donskov, Frede


Book ID
119939984
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
302 KB
Volume
23
Category
Article
ISSN
1044-579X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Relevance of clinical trials in acute my
โœ Apostolia M. Tsimberidou; Elihu Estey ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 57 KB

## Abstract Patients with newly diagnosed acute myeloid leukaemia (AML) are increasingly being enrolled in clinical trials sponsored by pharmaceutical companies or the National Cancer Institute. These trials routinely exclude patients who are less likely to respond (LLTR), e.g. those with Zubrod pe

Prognostic factors observed in current c
โœ F. Andrew Dorr ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 586 KB

Adjuvant therapy of breast cancer has evolved over the past 15 years from an interesting clinical experiment to the standard of care for many patients. The toxicities of different treatments vary from those with minimal side effects, such as tamoxifen, to those with potentially lifethreatening side

Prognostic relevance of clinical pharmac
โœ Riccardi, Riccardo ;Lasorella, Anna ;Mastrangelo, Renato ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 364 KB

Response to treatment is the most important prognostic factor in children undergoing treatment for acute lymphoblastic leukemia. Factors that interfere with the pharmacokinetic determinants of anti-leukemic compounds may cause a decreased activity of one or more of the drugs included in the treatmen